Showing results (111-120 of 639) with videos related to
Sort By:
Pageof 64
Current Opinion in Rheumatology|March 20, 2008
The epidemiology of glucocorticoid-associated adverse eventsAllyson K McDonough, Jeffrey R Curtis, Kenneth G SaagTherapeutic Advances in Musculoskeletal Disease|July 20, 2018
Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithmAlvin Lee Day, Sarah L Morgan, Kenneth G SaagAnnals of the Rheumatic Diseases|July 24, 2010
From bone biology to clinical outcome: state of the art and future perspectivesGeorg Schett, Kenneth G Saag, Johannes W J BijlsmaRheumatic Diseases Clinics of North America|April 7, 2019
Tools and Methods for Real-World Evidence Generation: Pragmatic Trials, Electronic Consent, and Data LinkagesJeffrey R Curtis, P Jeff Foster, Kenneth G SaagJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 7, 2009
The effect of serum urate on gout flares and their associated costs: an administrative claims analysisRachel Halpern, Mahesh J Fuldeore, Reema R Mody, et al.Arthritis Care & Research|August 31, 2023
Development of an Interactive Tool to Support Shared Decision-Making in Rheumatoid Arthritis: Treatment Attribute PreferenceJeffrey R Curtis, Kerri Ford, Stefano Fiore, et al.Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onsetJiha Lee, Sofia Pedro, Sara H Bares, et al.Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 24, 2022
Coadministration of Immunosuppressant Treatments With Pegloticase in the Context of Solid-Organ Transplantation and Gout: A Case ReportAnna Kilzer, Lauren Klingemann, Ted R Mikuls, et al.Current Medical Research and Opinion|June 3, 2009
Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysisRachel Halpern, Reema R Mody, Mahesh J Fuldeore, et al.Rheumatic Diseases Clinics of North America|July 7, 2019
Vascular Consequences of Hyperuricemia and HypouricemiaDaniel Albert, Paige N Scudder, Pamela Bagley, et al.Pageof 64